Chemical Structure (Everolimus 01)
Everolimus Tablet
Product Images NDC 51991-985
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 51991-985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Everolimus 02)
This appears to be a table of some sort, with headings listed as "CGFR (MDRD 4) (ml,/min/1.78m*+2)", "Sc", "D3", "W2", "Wi", "Wb", "W6", "Mz", "M3", "Ma", "Neb", "M5", "M6", "Mo", "NIz", "Mip", and "W24". The numbers listed under each heading vary between 0 and 110. It is likely that this table is related to a medical study or experiment, possibly involving different treatment groups.*
Principal Display Panel (0.25 mg Tablet Blister Pack Carton)
This is a medication called Everolimus Tablets, available in 025 mg and 25 mg per tablet dosages, and the package insert provides information on how to store the medication properly, and a warning to keep it away from children. The medication guide is enclosed for dispensing purposes. The manufacturer is Nato Pharma Limited and it is distributed in the USA by Berkn, CT. The NDC numbers for the respective dosages are 51991-37860 and 51991-37960.*
Principal Display Panel (0.25 mg Tablet Blister Pack)
This is a description of two different NDC codes (51991-379-99 and 51991-379-09) for Everolimus Tablet at a strength of 0.25 mg. The tablets were distributed by two different companies, Breci Pharma and Brockenridge Pharmaceutical Inc., respectively. The location of Breci Pharma is given as Berlin, CT and the location of Brockenridge Pharmaceutical Inc. is given as either Berlin, CT or Berea, CT with various dates listed. Natco Pharma Ltd. in India is also mentioned as an identifier in the distribution. The text contains some inaccuracies and confusion in the formatting, making it difficult to read.*
Principal Display Panel (0.5 mg Tablet Blister Pack Carton)
Principal Display Panel (0.5 mg Tablet Blister Pack)
Principal Display Panel (0.75 mg Tablet Blister Pack Carton)
This is a description of a medication called Everolimus Tablets. The dosage details are mentioned and instructions about storage and handling are given. The manufacturer and distributor details are also mentioned, along with information about reporting side effects. The medication is only available with a prescription, and it comes in a carton containing six individual blisters with ten tablets each. The text also mentions the strength of the tablets, which is 0.75 mg per tablet.*
Principal Display Panel (0.75 mg Tablet Blister Pack)
This is a set of -generated labels for Everolimus tablets. The labels contain the drug's strength (0.75 mg), its National Drug Code (NDC) number (51991-381-99), and the name of the pharmaceutical company that distributed the tablets (Breckenridge Pharmaceutical or Breckenridge Pharmacautical Inc.) along with their address. The labels also show the date the tablets were packaged (in various formats such as "0412021" or "042021 1 5 | 45").*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
